61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Johnson and Johnson
Closed
Sector Healthcare
146.49 1.87
Overview
Share price change
24h
Min
143.7
Max
146.6
Income | -2B 2.7B |
|---|---|
Sales | 50M 23B |
P/E Sector Avg | 24.52 87.008 |
EPS | 2.42 |
Dividend yield | 3.142 |
Profit margin | 11.973 |
Employees | 131,900 |
EBITDA | -2.4B 5.4B |
Recommendations | Buy |
|---|---|
12 Months Forecast | +22.99 upside |
Dividend yield Sector Avg | 3.14% 2.48% |
|---|---|
Next Earnings | 22 Jan 2025 |
Next Dividend date | 4 Mar 2025 |
Next Ex Dividend date | 14 Feb 2025 |
Market Cap | -4.4B 354B |
|---|---|
Previous open | 144.62 |
Previous close | 146.49 |
News Sentiment
By Acuity
61%
39%
339 / 392 Healthcare
Technical Score
By Trading Central
Confidence
Bearish Evidence
Johnson and Johnson Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Johnson and Johnson Forecast
Price Target
By TipRanks
22.99% upside
12 Months Forecast
Average 176.92 USD 22.99%
High 215 USD
Low 159 USD
Based on 14 Wall Street analysts offering 12 month price targets forJohnson and Johnson - Dist in the last 3 months.
Sentiment
By Acuity
339 / 392 Healthcare
News Sentiment
Bearish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Johnson and Johnson
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopedic, surgery, and vision fields.
